Krystal Biotech to Present at Stifel 2024 Healthcare Conference
Krystal Biotech (NASDAQ: KRYS) announced its participation in the Stifel 2024 Healthcare Conference on November 18, 2024, in New York. Chairman and CEO Krish S. Krishnan will participate in a fireside chat at 10:55 am ET and conduct investor meetings throughout the day. The presentation will be accessible via webcast and will be available on the company's website's Investors section.
Krystal Biotech (NASDAQ: KRYS) ha annunciato la sua partecipazione alla Stifel 2024 Healthcare Conference il 18 novembre 2024, a New York. Il presidente e CEO Krish S. Krishnan parteciperà a una chiacchierata informale alle 10:55 ET e condurrà incontri con gli investitori durante tutta la giornata. La presentazione sarà accessibile tramite webcast e sarà disponibile nella sezione Investitori del sito web dell'azienda.
Krystal Biotech (NASDAQ: KRYS) anunció su participación en la Stifel 2024 Healthcare Conference el 18 de noviembre de 2024, en Nueva York. El presidente y CEO Krish S. Krishnan participará en una charla informal a las 10:55 am ET y llevará a cabo reuniones con inversores durante todo el día. La presentación será accesible a través de una transmisión en vivo y estará disponible en la sección de Inversores del sitio web de la empresa.
크리스탈 바이오텍 (NASDAQ: KRYS)는 2024년 11월 18일 뉴욕에서 열리는 스티펠 2024 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회장 겸 CEO인 크리슈 S. 크리슈난은 오전 10:55 ET에 파이어사이드 챗에 참석하고 하루 종일 투자자 미팅을 진행할 예정입니다. 발표는 웹캐스트를 통해 접근 가능하며 회사 웹사이트의 투자자 섹션에서 확인할 수 있습니다.
Krystal Biotech (NASDAQ: KRYS) a annoncé sa participation à la Stifel 2024 Healthcare Conference le 18 novembre 2024 à New York. Le président et PDG Krish S. Krishnan participera à une discussion informelle à 10h55 ET et tiendra des réunions avec des investisseurs tout au long de la journée. La présentation sera accessible par webcast et sera disponible dans la section Investisseurs du site web de l'entreprise.
Krystal Biotech (NASDAQ: KRYS) gab seine Teilnahme an der Stifel 2024 Healthcare Conference am 18. November 2024 in New York bekannt. Der Vorsitzende und CEO Krish S. Krishnan wird um 10:55 Uhr ET an einem Fireside Chat teilnehmen und den ganzen Tag über Investorenmeetings durchführen. Die Präsentation wird über ein Webcast zugänglich sein und im Bereich Investoren der Website des Unternehmens verfügbar sein.
- None.
- None.
PITTSBURGH, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the Stifel 2024 Healthcare Conference on November 18, 2024, in New York. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 10:55 am ET and host investor meetings throughout the day.
A webcast of the presentation will be available here beginning at 10:55 am ET on Monday, November 18, 2024 and will be posted on the Investors section of the Company’s website.
About Krystal Biotech, Inc.
Krystal Biotech, Inc. (NASDAQ: KRYS) is a commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK® is the Company’s first commercial product, the first-ever redosable gene therapy, and the first medicine approved by the FDA for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines in respiratory, oncology, dermatology, ophthalmology, and aesthetics. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. For more information, please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and X (formerly Twitter).
CONTACT
Investors and Media:
Stéphane Paquette
Krystal Biotech
spaquette@krystalbio.com
FAQ
When is Krystal Biotech presenting at the Stifel 2024 Healthcare Conference?
Will the Krystal Biotech (KRYS) Stifel Conference presentation be available online?
Who will represent Krystal Biotech (KRYS) at the Stifel 2024 Healthcare Conference?
